Top 15 Medical VC Funds & Investors in New Zealand (May 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Pacific Channel
VC Fund
|
2 | New Zealand | Seed, Series A | Medical Device, Medical, Health Care | |
|
Enterprise Angels
VC Fund
|
2 | New Zealand, United States, United Kingdom | Seed, Angel | Software, Information Technology, Health Care | $149k–$2.4M |
|
IP Group
VC Fund
|
2 | United Kingdom, United States, Australia | Seed, Series A, Series B | Health Care, Biotechnology, Therapeutics | $369k–$61M |
|
Matū Fund
VC Fund
|
2 | New Zealand, United States | Seed | Biotechnology, Robotics, Nanotechnology | |
|
Icehouse Ventures
VC Fund
|
2 | New Zealand, United States, Australia | Seed, Series A | Software, SaaS, Information Technology | $450k–$21M |
|
ArcAngels
VC Fund
|
1 | New Zealand | Series A | Medical, Genetics, Health Care | |
|
Sante Ventures
VC Fund
|
1 | United States, Canada, New Zealand | Series A, Series B, Series C | Health Care, Biotechnology, Medical | $1M–$30M |
|
New Zealand Growth Capital Partners
VC Fund
|
1 | New Zealand, United States | Seed, Series A | Software, SaaS, Manufacturing | $1.3M–$6.2M |
|
Global from Day One
VC Fund
|
1 | New Zealand, United States, China | Seed, Series A | Software, SaaS, Medical Device | $595k–$5M |
|
Movac
VC Fund
|
1 | New Zealand, United States, Australia | Seed, Series A | Software, E-Commerce, SaaS | $774k–$16M |
|
New Zealand Venture Investment Fund
VC Fund
|
1 | New Zealand, United States, Japan | Seed, Series A, Angel | Software, Biotechnology, SaaS | $400k–$8.5M |
|
Cure Kids Ventures
VC Fund
|
1 | New Zealand | Seed, Pre-Seed, Series A | Medical Device, SaaS, Medical | |
|
Uniservices
VC Fund
|
1 | New Zealand | Seed, Pre-Seed | Medical Device, SaaS, Audio | |
|
AngelHQ
VC Fund
|
1 | New Zealand, United States, Canada | Seed, Angel, Series A | Software, Artificial Intelligence, SaaS | $357k–$1.5M |
|
K1W1
VC Fund
|
1 | New Zealand, United States | Seed, Series A | Software, Biotechnology, SaaS | |
| Access all 19 VC funds in New Zealand Medical startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
Investing in great people solving hard problems to create a better future.
Show more...Investment focus
- Industry: Medical Device, Medical, Health Care
- Stage:Seed, Series A
- Geography: New Zealand
Investor stats
- Total investments: 8
- Lead/follow: 38% lead, 62% follow
Portfolio highlights
- Orbica — Orbica develops innovative, cross-industry location data solutions, services and products.
- Avasa — Avasa is a medical device company. It helps to improve surgical procedures by developing novel implantable devices.
- Kitea Health — Kitea Health creates pressure monitoring implantable medical devices.
Connecting startup business owners with angel investors to raise capital . Access a network of expertise and investment opportunities.
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Seed, Angel
- Geography: New Zealand, United States, United Kingdom
Investor stats
- Total investments: 98
- Round size: Seed $149k–$2.4M; Angel $223k–$655k
- Lead/follow: 7% lead, 93% follow
- Last fund: May invest from a new fund soon — raised $12M in 2019
Portfolio highlights
- Cropsy Technologies — Cropsy's mission is to deliver disruptive, scalable technology to every fruit grower to unlock the full potential of their land with insights that were impossible before. Our proprietary AI-enabled hardware allows growers to monitor every plant, understand the whole crop, and track how it changes over time. These insights help growers optimiseall their decision making. The system is a simple tractor add-on, so growers do all their daily operations while Cropsy looks out for problems. Cropsy is poised to set the new gold standard for growing, with recommendations, forecasts, and providing certainty to every grower, every season.
- Cetogenix — Cetogenix is a clean technology business dedicated to creating long-term solutions to global climate change.
- Zenno Astronautics — At Zenno Astronautics, our hardware and software products ensure satellite missions are effectively managed, guaranteeing maximum economic returns and responsible use of space.
IP Group's core business is the creation of value for its shareholders and partners through the commercialisation of intellectual property originating from research intensive institutions. Their strength lies in managing this process from finding suitable intellectual property to commercialise to either helping develop businesses and createvalue out of them, or identifying and establishing appropriate commercial partnerships to do so. IP Group's extensive expertise in this area combined with its inside knowledge of both industry and finance have enabled the group to create a formidable track record of consistently delivering excellent results for their companies, for their partners and for their shareholders.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Therapeutics
- Stage:Seed, Series A, Series B
- Geography: United Kingdom, United States, Australia
Investor stats
- Total investments: 157
- Round size: Seed $369k–$6.4M; Series A $1.8M–$17M; Series B $7.4M–$61M
- Lead/follow: 24% lead, 76% follow
- Last fund: May invest from a new fund soon — last raise in 2014
Portfolio highlights
- AccelerComm — Our patented, market-leading IP solutions for 4G and 5G are configurable for quick, high-performance implementations across a wide range of applications.
- Deep Render — Deep Render Ltd. is a spin-out from the Department of Computing at Imperial College London. We are a London based AI start-up that is developing the next generation of media compression algorithms. Our proprietary and patented technology is at the forefront of machine learning research. Furthermore, our Biological Image Compression results arestate-of-the-art, providing at least a 50% efficiency gain over the previous standards
- Crescendo Biologics — Crescendo Biologics is a new Cambridge-based company whose vision is to deliver next-generation antibody therapeutics based on novel class-leading platforms.The focus of the company is on developing platforms that will address key issues in generating high-affinity, soluble, human VH antibody fragments. These are the smallest fragments thatretain antibody binding, and have many desirable properties as potential therapeutics. Crescendo will then utilise these platforms for product development of in-house targets or in partnership with other companies.
Investing in scalable science and deep tech start-ups in Aotearoa NZ. We operate venture capital funds that invest in science and deep tech through a hands-on, active approach.
Show more...Investment focus
- Industry: Biotechnology, Robotics, Nanotechnology
- Stage:Seed
- Geography: New Zealand, United States
Investor stats
- Total investments: 7
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Ligar — Novel technology to rapidly and cost effectively capture and recover specific molecules or groups of molecules from liquids, such as bioactives, bitter flavours or contaminants from natural extracts, wine, water, juices, coffee and wastewater. [et_pb_column type="1_3"
- Alimetry — Alimetry is a health technology startup based in Auckland, New Zealand, developing breakthrough solutions for diagnosing disorders of gastrointestinal (GI) function.
- PowerON — Dielectric Elastomers for Soft Robotics
Icehouse Ventures is an early-stage venture capital firm. We exist to back the world's bravest Kiwi founders, launching global companies from New Zealand.
Show more...Investment focus
- Industry: Software, SaaS, Information Technology
- Stage:Seed, Series A
- Geography: New Zealand, United States, Australia
Investor stats
- Total investments: 125
- Round size: Seed $450k–$2.6M; Series A $1.4M–$21M
- Lead/follow: 10% lead, 90% follow
- Last fund: Likely still investing — fund raised in 2021
Portfolio highlights
- DataMasque — Simply mask your sensitive data while maintaining its function for testing, development, training and analytics. DataMasque makes it safe to explore, implement and harness the opportunities that data provides, free from privacy concerns or compromise.
- Aquila — We're powering the future by building and operating an infinitely scalable energy network.
- Scentian Bio — Scentian Bio operates as a platform that provides ultimate sensing solution.
At ArcAngels Funding, we connect female entrepreneurs across New Zealand to venture capital and investment to help their businesses grow.
Show more...Investment focus
- Industry: Medical, Genetics, Health Care
- Stage:Series A
- Geography: New Zealand
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Engender Technologies — Engender has developed a proprietary process to separate X (female) and Y (male) bearing bull sperm cells, enabling dairy farmers to accelerate genetic gain and improve productivity. Engender has secured scientific and laboratory facilities from one of the world’s largest AI companies in exchange for an option for it to non-exclusively licenseEngender’s technology.
Santé Ventures is a life sciences venture capital firm that invests exclusively in early-stage companies developing innovative new medical technologies or healthcare delivery models. The firm was founded in 2006 and has $281 million in capital under management in two funds.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series A, Series B, Series C
- Geography: United States, Canada, New Zealand
Investor stats
- Total investments: 81
- Round size: Series A $1M–$25M; Series B $2.6M–$30M; Series C $3.5M–$12M
- Lead/follow: 70% lead, 30% follow
- Last fund: Likely still investing — fund raised in 2021
Portfolio highlights
- BeeKeeperAI — BeeKeeperAI is a zero trust collaboration platform protecting both algorithm IP and regulated data.
- Solu Therapeutics — Solu Therapeutics is a precision-medicine-focused company developing therapeutics to eliminate disease-driving cells.
- Surgical Safety Technologies — Surgical Safety Technologies delivers data-driven AI technology to hospitals for safe surgeries. It empowers surgeons with an objective assessment of technical and non-technical proficiency using academically validated frameworks.
The New Zealand Growth Capital Partners (formerly New Zealand Venture Investment Fund) was established to support early-stage technology companies and to stimulate private investment into this space.
Show more...Investment focus
- Industry: Software, SaaS, Manufacturing
- Stage:Seed, Series A
- Geography: New Zealand, United States
Investor stats
- Total investments: 15
- Round size: Seed $1.3M–$6.2M
- Lead/follow: 6% lead, 94% follow
Portfolio highlights
- Aquafortus — Aquafortus specializes in providing enviornmental services and commercializes proprietary zero liquid discharge technology.
- Avasa — Avasa is a medical device company. It helps to improve surgical procedures by developing novel implantable devices.
- Kitea Health — Kitea Health creates pressure monitoring implantable medical devices.
GD1 is a Venture Capital firm that invests with high conviction in exciting technology companies originating from New Zealand. Our team is passionate about creating and growing global businesses, and our goal is to transform NZ made into the next generation of globally disruptive tech solutions.
Show more...Investment focus
- Industry: Software, SaaS, Medical Device
- Stage:Seed, Series A
- Geography: New Zealand, United States, China
Investor stats
- Total investments: 27
- Round size: Seed $595k–$5M
- Lead/follow: 33% lead, 67% follow
- Last fund: Likely still investing — fund raised in 2021
Portfolio highlights
- eVouch — eVouch is the most powerful marketing tool we've used to build an organic community. We've experienced elevated brand trust while reaching an audience we never thought possible. Using customers to market to their friends is simply genius.
- Flowingly — Unlock Team Productivity. Streamline Approvals. Increase Compliance. Easy To Use, No-Code Process Mapping & Workflow Automation Platform.
- Formus Labs — Formus Labs develops software technologies for orthopedic planning and analysis. Our mission is to improve outcomes and efficiencies through seamless and highly scalable integration of AI and computational modelling in the orthopedic clinical workflow. Based in Auckland, New Zealand, Formus Labs draws on over 10 years of research andcommercialisation experience, with operations in New Zealand, Australia, and soon in the USA.
Movac is New Zealand's most experienced technology investor and is deeply integrated into the Kiwi tech sector. We've been actively investing since 1998.
Show more...Investment focus
- Industry: Software, E-Commerce, SaaS
- Stage:Seed, Series A
- Geography: New Zealand, United States, Australia
Investor stats
- Total investments: 30
- Round size: Seed $1.4M–$4.3M; Series A $774k–$16M
- Lead/follow: 43% lead, 57% follow
- Last fund: May invest from a new fund soon — last raise in 2016
Portfolio highlights
- Atomic — Atomic embeds native, actionable customer interaction inside your iOS, Android or web app. Turn your customer data and insights into loyalty, retention and conversion.
- ZeroJet — ZeroJet is the first jet propulsion system to be designed specifically for an electric motor, delivering the perfect balance of performance and runtime.
- Mint Innovation — Founded in 2016, members of the Mint Innovation team have a strong background in chemistry, biotechnology, and leveraging IP in the industrial sector. They are scaling their technology in their Auckland plant and labs to demonstrate the commercial application of their biometallurgy processes for metal recovery.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Your guide to finding and using government services.
Show more...Investment focus
- Industry: Software, Biotechnology, SaaS
- Stage:Seed, Series A, Angel
- Geography: New Zealand, United States, Japan
Investor stats
- Total investments: 35
- Round size: Seed $417k–$1.2M; Angel $400k–$417k; Series A $1.4M–$8.5M
- Lead/follow: 6% lead, 94% follow
Portfolio highlights
- Insite AI — We create predictability for consumer brands in the unpredictable world of retail. Game-changing technology that attacks consumer brands' hardest problems.
- Invert Robotics — Invert Robotics develops robotic NDT inspection technologies for the maintenance of industrial equipment in the food and beverage, pharmaceutical, and oil and gas industries. Invert Robotics highly skilled team of engineers have developed a world leading modular inspection platform suitable for use across a range of industries and applications.
- Surgical Design Studios — The Insides Company is the leading provider of chyme reinfusion solutions for intestinal failure
Investing in innovation for a healthy childhood Investing in innovation for a healthy childhood About Cure Kids Ventures Cure Kids Ventures is a seed and early stage investment fund that invests in the commercialisation of innovations in products and services with a potential to
Show more...Investment focus
- Industry: Medical Device, SaaS, Medical
- Stage:Seed, Pre-Seed, Series A
- Geography: New Zealand
Investor stats
- Total investments: 4
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Avasa — Avasa is a medical device company. It helps to improve surgical procedures by developing novel implantable devices.
- Formus Labs — Formus Labs develops software technologies for orthopedic planning and analysis. Our mission is to improve outcomes and efficiencies through seamless and highly scalable integration of AI and computational modelling in the orthopedic clinical workflow. Based in Auckland, New Zealand, Formus Labs draws on over 10 years of research andcommercialisation experience, with operations in New Zealand, Australia, and soon in the USA.
- Kitea Health — Kitea Health creates pressure monitoring implantable medical devices.
Auckland University's commercialisation arm
Show more...Investment focus
- Industry: Medical Device, SaaS, Audio
- Stage:Seed, Pre-Seed
- Geography: New Zealand
Investor stats
- Total investments: 4
- Lead/follow: no public data
Portfolio highlights
- Alimetry — Alimetry is a health technology startup based in Auckland, New Zealand, developing breakthrough solutions for diagnosing disorders of gastrointestinal (GI) function.
- Avasa — Avasa is a medical device company. It helps to improve surgical procedures by developing novel implantable devices.
- Formus Labs — Formus Labs develops software technologies for orthopedic planning and analysis. Our mission is to improve outcomes and efficiencies through seamless and highly scalable integration of AI and computational modelling in the orthopedic clinical workflow. Based in Auckland, New Zealand, Formus Labs draws on over 10 years of research andcommercialisation experience, with operations in New Zealand, Australia, and soon in the USA.
Angel HQ is Wellington region's angel investment network - follow us for angel investing info, and a way to connect to local, national and international angels.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, SaaS
- Stage:Seed, Angel, Series A
- Geography: New Zealand, United States, Canada
Investor stats
- Total investments: 12
- Round size: Seed $893k–$1.5M; Angel $357k–$1M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Hnry — Hnry automatically pays and files all taxes for contractors, freelancers, and sole traders, so they never have to think about tax again.
- Cropsy Technologies — Cropsy's mission is to deliver disruptive, scalable technology to every fruit grower to unlock the full potential of their land with insights that were impossible before. Our proprietary AI-enabled hardware allows growers to monitor every plant, understand the whole crop, and track how it changes over time. These insights help growers optimiseall their decision making. The system is a simple tractor add-on, so growers do all their daily operations while Cropsy looks out for problems. Cropsy is poised to set the new gold standard for growing, with recommendations, forecasts, and providing certainty to every grower, every season.
- Cetogenix — Cetogenix is a clean technology business dedicated to creating long-term solutions to global climate change.
K1W1 provides startups and businesses in New Zealand with early and later-stage venture investments.
Show more...Investment focus
- Industry: Software, Biotechnology, SaaS
- Stage:Seed, Series A
- Geography: New Zealand, United States
Investor stats
- Total investments: 61
- Lead/follow: no public data
Portfolio highlights
- Daisy Lab — Daisy Lab pioneers precision fermentation technology in New Zealand
- Aquafortus — Aquafortus specializes in providing enviornmental services and commercializes proprietary zero liquid discharge technology.
- Mint Innovation — Founded in 2016, members of the Mint Innovation team have a strong background in chemistry, biotechnology, and leveraging IP in the industrial sector. They are scaling their technology in their Auckland plant and labs to demonstrate the commercial application of their biometallurgy processes for metal recovery.
Medical VC funding in New Zealand at a glance
Stats across 11 deals from 19 investors.
Access all 19 VC funds in New Zealand Medical startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Medical VC Funds in New Zealand investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 19 VC funds investing in New Zealand Medical startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!